Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends' HRD Harmonization Project ...

Matthew Mega highlighted the significance of Medicare coverage for the genome-based Signatera assay, noting it validates both the test's clinical utility and its analytical accuracy.

The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for identifying recurrence risks in patients with early-stage melanoma who do ...

You might think digital calipers are more accurate, in practice, they are surprisingly accurate, although the digital units are easier to read.

The addition of these assays further propels PerkinElmer’s ability to provide end-to-end solutions for oncology researchers, which includes early stage drug discovery with assays, cell lines ...

Kinases and kinase assays are all about domino effects. To tip the first domino in a drug development effort, try tracking kinase activity biochemically—or through signaling cascades in vivo.

When selecting a kinase assay, drug developers look for the best “fit”—biochemically as well as practically. Detection technologies, reagents, and profiling services are all relevant.

Assays that measure kinase functional activity in key pathways in a physiologically relevant cellular context enable oncology researchers, as well as researchers in other therapeutic areas, to ...